Prolonged heparin after uncomplicated coronary interventions: a prospective, randomized trial

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Trials

Background:

• Continuous heparin infusion post-percutaneous transluminal coronary angioplasty (PTCA) is associated with prolonged hospital stays and increased bleeding risk.
• Uncomplicated coronary interventions, including stent implantation, necessitate evaluating heparin's role.

Purpose of the Study:

• To assess if omitting post-procedure heparin infusion after successful PTCA increases acute cardiac complications.
• To evaluate the safety and efficacy of heparin omission in patients with stable and unstable angina.

Main Methods:

• A randomized trial involving 191 patients undergoing successful PTCA.
• Patients were assigned to either prolonged heparin infusion or no postprocedure heparin.
• Stent usage was recorded, and cardiac and peripheral vascular complications were monitored.

Main Results:

• No significant increase in acute cardiac complications was observed in the heparin omission group (4% vs 4% myocardial infarction).
• Peripheral vascular complications were slightly higher in the heparin group (3% vs 1%).
• No repeat revascularization was needed during hospitalization in either group.

Conclusions:

• Omission of heparin after successful PTCA, with or without stenting, is safe for patients with stable and unstable angina.
• Early sheath removal, shorter hospital stays, and cost savings are benefits of heparin omission.
• Evidence suggests routine post-procedure heparin use after uncomplicated coronary interventions may not be necessary.